![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ZNF445 |
Gene summary for ZNF445 |
![]() |
Gene information | Species | Human | Gene symbol | ZNF445 | Gene ID | 353274 |
Gene name | zinc finger protein 445 | |
Gene Alias | ZFP445 | |
Cytomap | 3p21.31 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | P59923 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
353274 | ZNF445 | HCC1_Meng | Human | Liver | HCC | 5.26e-51 | 7.60e-02 | 0.0246 |
353274 | ZNF445 | HCC2_Meng | Human | Liver | HCC | 2.03e-04 | -2.21e-02 | 0.0107 |
353274 | ZNF445 | HCC1 | Human | Liver | HCC | 1.93e-11 | 2.84e+00 | 0.5336 |
353274 | ZNF445 | HCC2 | Human | Liver | HCC | 9.57e-21 | 3.12e+00 | 0.5341 |
353274 | ZNF445 | HCC5 | Human | Liver | HCC | 6.16e-11 | 2.86e+00 | 0.4932 |
353274 | ZNF445 | S014 | Human | Liver | HCC | 3.78e-04 | 3.30e-01 | 0.2254 |
353274 | ZNF445 | S015 | Human | Liver | HCC | 9.35e-04 | 3.78e-01 | 0.2375 |
353274 | ZNF445 | S016 | Human | Liver | HCC | 2.28e-04 | 3.20e-01 | 0.2243 |
353274 | ZNF445 | S028 | Human | Liver | HCC | 5.29e-10 | 5.32e-01 | 0.2503 |
353274 | ZNF445 | S029 | Human | Liver | HCC | 1.86e-05 | 5.11e-01 | 0.2581 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Breast | Precancer | ![]() |
Breast | IDC | ![]() |
Breast | DCIS | ![]() |
Cervix | CC | ![]() |
Cervix | HSIL_HPV | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZNF445 | SNV | Missense_Mutation | novel | c.795N>T | p.Glu265Asp | p.E265D | P59923 | protein_coding | deleterious(0.01) | probably_damaging(0.926) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ZNF445 | SNV | Missense_Mutation | rs754731745 | c.185N>A | p.Arg62His | p.R62H | P59923 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-AN-A0AJ-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ZNF445 | SNV | Missense_Mutation | c.2420G>T | p.Arg807Leu | p.R807L | P59923 | protein_coding | deleterious(0.03) | possibly_damaging(0.892) | TCGA-AO-A1KT-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | fluorouracil | SD | |
ZNF445 | SNV | Missense_Mutation | c.1274C>T | p.Ser425Leu | p.S425L | P59923 | protein_coding | deleterious(0.02) | benign(0.254) | TCGA-BH-A0DX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | CR | |
ZNF445 | SNV | Missense_Mutation | c.1393N>C | p.Asp465His | p.D465H | P59923 | protein_coding | tolerated(0.15) | benign(0.359) | TCGA-D8-A1J8-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | nolvadex | SD | |
ZNF445 | SNV | Missense_Mutation | novel | c.1986N>A | p.Phe662Leu | p.F662L | P59923 | protein_coding | tolerated(0.2) | benign(0) | TCGA-OL-A66L-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ZNF445 | insertion | Frame_Shift_Ins | novel | c.1914_1915insGG | p.Asn639GlyfsTer7 | p.N639Gfs*7 | P59923 | protein_coding | TCGA-A8-A06X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
ZNF445 | insertion | In_Frame_Ins | novel | c.1913_1914insCCATACACCAGGCGCTGGTGTGTTTGCCAGAGACCCAGC | p.Ser638_Asn639insHisThrProGlyAlaGlyValPheAlaArgAspProAla | p.S638_N639insHTPGAGVFARDPA | P59923 | protein_coding | TCGA-A8-A06X-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
ZNF445 | insertion | Frame_Shift_Ins | novel | c.2788_2789insGATTCTGT | p.Ala930GlyfsTer13 | p.A930Gfs*13 | P59923 | protein_coding | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
ZNF445 | SNV | Missense_Mutation | c.1039N>A | p.Glu347Lys | p.E347K | P59923 | protein_coding | tolerated(0.1) | benign(0.093) | TCGA-C5-A1BI-01 | Cervix | cervical & endocervical cancer | Female | <65 | III/IV | Chemotherapy | cisplatin | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |